切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2023, Vol. 10 ›› Issue (03) : 152 -158. doi: 10.3877/cma.j.issn.2095-7157.2023.03.003

论著

消化道恶性肿瘤活动性出血不同内镜下止血方法的对比研究
蔡朝蓓, 李惠凯, 高飞, 韩珂, 令狐恩强()   
  1. 100853 北京,解放军总医院第一医学中心消化内科医学部;100853 北京,解放军医学院
    100853 北京,解放军总医院第一医学中心消化内科医学部
  • 收稿日期:2023-05-15 出版日期:2023-08-15
  • 通信作者: 令狐恩强
  • 基金资助:
    国家重点研发计划(2022YFC2503600)

A comparison between different endoscopic hemostatic methods for active bleeding from malignant gastrointestinal cancers

Zhaobei Cai, Huikai Li, Fei Gao, Ke Han, Enqiang Linghu()   

  1. Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China; Chinese PLA Medical School, Beijing 100853, China
    Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
  • Received:2023-05-15 Published:2023-08-15
  • Corresponding author: Enqiang Linghu
引用本文:

蔡朝蓓, 李惠凯, 高飞, 韩珂, 令狐恩强. 消化道恶性肿瘤活动性出血不同内镜下止血方法的对比研究[J]. 中华胃肠内镜电子杂志, 2023, 10(03): 152-158.

Zhaobei Cai, Huikai Li, Fei Gao, Ke Han, Enqiang Linghu. A comparison between different endoscopic hemostatic methods for active bleeding from malignant gastrointestinal cancers[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(03): 152-158.

目的

探讨不同内镜下止血方法对于消化道恶性肿瘤活动性出血的止血效果。

方法

回顾性分析2001年1月至2022年3月经解放军总医院第一医学中心消化内科医学部行内镜下止血的消化道恶性肿瘤活动性出血患者的相关临床资料,根据是否只应用肾上腺素行内镜下止血治疗,将患者分为单纯肾上腺素组和其他内镜治疗组(包括内镜下联合肾上腺素止血),比较两组的即刻止血成功率。

结果

共纳入65例消化道恶性肿瘤活动性出血患者,其中单纯肾上腺素组34例、其他内镜治疗组31例,两组的即刻止血成功率分别为82.4% (28/34)、100% (31/31),组间对比差异有统计学意义(P=0.025)。内镜操作时间分别为17.5(12,21)min、22(14,36)min,差异有统计学意义(P=0.020)。两组间对比内镜止血后24 h和72 h再出血率,差异均无统计学意义。

结论

对于消化道恶性肿瘤活动性出血的治疗,内镜下电凝止血、机械止血及组织胶注射止血等方法或上述方法与肾上腺素联合使用,优于单纯应用肾上腺素。

Objective

This study aimed to investigate the hemostatic contribution of various endoscopic hemostasis methods in managing active hemorrhage caused by gastrointestinal malignancies.

Methods

In this study, we conducted a retrospective analysis of the medical records of patients who underwent endoscopic hemostasis to stop active bleeding in gastrointestinal malignancies at the First Medical Center of the PLA General Hospital between January 2001 and March 2022. Patients were divided into two groups based on the endoscopic hemostasis they received: the epinephrine-only group and the other endoscopic hemostatic treatments group, which included a combination with epinephrine.The primary outcome of this research was a comparison of the success rates of hemostasis between the two groups.

Results

The study involved 65 individuals who had gastrointestinal malignancies with active bleeding.Of these, 34 were treated solely with epinephrine, while 31 received other endoscopic hemostatic treatments.The immediate hemostasis rates were 82.4% (28/34) and 100% (31/31), respectively, and the difference between the two groups was statistically significant (P=0.025). The endoscopic procedure durations were 17.5(12, 21) minutes and 22(14, 36) minutes for the two groups, respectively, with a statistically significant difference (P=0.020). The rates of rebleeding at 24 and 72 hours after endoscopic hemostasis were not significantly different between the two groups.

Conclusion

For the endoscopic management of gastrointestinal malignant active bleeding, electrocoagulation, mechanical hemostasis, cyanoacrylate injection, or a combination of these techniques with epinephrine are preferable than utilizing adrenaline alone.

图1 患者筛选流程图
表1 纳入患者的临床基线资料[例(%)]
表2 消化道恶性肿瘤的基线特征[例(%)]
表3 各个观察指标的分布特征[例(%)]
表4 其他内镜治疗组的止血方法
[1]
Baer CMenon RBastawrous S,et al.Emergency Presentations of Colorectal Cancer[J].Surg Clin North Am201797(3):529-545.
[2]
Sverdén EMarkar SRAgreus L,et al.Acute upper gastrointestinal bleeding[J].BMJ2018363:k4023.
[3]
van Leerdam MEVreeburg EMRauws EA,et al.Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000[J].Am J Gastroenterol200398(7):1494-1499.
[4]
Cho SHLee YSKim YJ,et al.Outcomes and Role of Urgent Endoscopy in High-Risk Patients With Acute Nonvariceal Gastrointestinal Bleeding [J].Clin Gastroenterol Hepatol201816(3):370-377.
[5]
Gunderman RLeef JALipton MJ,et al.Diagnostic imaging and the outcome of acute lower gastrointestinal bleeding[J].Acad Radiol19985 (Suppl 2):S303-305.
[6]
Barkun ANAlmadi MKuipers EJ,et al.Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group[J].Ann Intern Med2019171(11):805-822.
[7]
Barnert JMessmann H.Diagnosis and management of lower gastrointestinal bleeding[J].Nat Rev Gastroenterol Hepatol20096(11): 637-646.
[8]
Heller SJTokar JLNguyen MT,et al.Management of bleeding GI tumors[J].Gastrointest Endosc201072(4):817-824.
[9]
Green BTRockey DCPortwood G,et al.Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage:a randomized controlled trial[J].Am J Gastroenterol2005100(11):2395-2402.
[10]
Kim YIChoi IJCho SJ,et al.Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer[J].J Gastroenterol Hepatol201328(9):1489-1495.
[11]
中国医师协会急诊医师分会,中华医学会急诊医学分会,全军急救医学专业委员会,等.急性上消化道出血急诊诊治流程专家共识(2020版)[J].中华急诊医学杂志202130(1):15-24.
[12]
Mourad FHLeong RW.Role of hemostatic powders in the management of lower gastrointestinal bleeding:A review[J].J Gastroenterol Hepatol2018, 33(8):1445-1453.
[13]
Sung HFerlay JSiegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin202171(3): 209-249.
[14]
Shabunin AVBagateliya ZAKorzheva IY,et al.Urgent surgical care for patients with colon cancer complicated by hemorrhage[J].Khirurgiia (Mosk)201787(12):46-51.
[15]
Loizou LABown SG.Endoscopic treatment for bleeding peptic ulcers: randomised comparison of adrenaline injection and adrenaline injection + Nd:YAG laser photocoagulation[J].Gut199132(10):1100-1103.
[16]
Laine LMcQuaid KR.Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials[J].Clin Gastroenterol Hepatol20097(1):33-47;quiz 31-32.
[17]
Suzuki HMiho OWatanabe Y,et al.Endoscopic laser therapy in the curative and palliative treatment of upper gastrointestinal cancer[J].World J Surg198913(2):158-164.
[18]
Laukka MAWang KK.Endoscopic Nd:YAG laser palliation of malignant duodenal tumors[J].Gastrointest Endosc199541(3):225-229.
[19]
Myszor MFRich AJBottrill P,et al.The impact of an endoscopic laser service on gastroenterological practice[J].Q J Med198970(261):73-79.
[20]
Kanai MHamada AEndo Y,et al.Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding[J].Endoscopy200436(12): 1085-1088.
[21]
Sagawa TTakayama TOku T,et al.Argon plasma coagulation for successful treatment of early gastric cancer with intramucosal invasion [J].Gut200352(3):334-339.
[22]
Akhtar KByrne JPBancewicz J,et al.Argon beam plasma coagulation in the management of cancers of the esophagus and stomach[J].Surg Endosc, 200014(12):1127-1130.
[23]
Wahab PJMulder CJden Hartog G,et al.Argon plasma coagulation in flexible gastrointestinal endoscopy:pilot experiences[J].Endoscopy1997, 29(3):176-181.
[24]
Chau CHSiu WTLaw BK,et al.Randomized controlled trial comparing epinephrine injection plus heat probe coagulation versus epinephrine injection plus argon plasma coagulation for bleeding peptic ulcers[J]. Gastrointest Endosc200357(4):455-461.
[25]
Kim JWJang JYLee CK,et al.Comparison of hemostatic forceps with soft coagulation versus argon plasma coagulation for bleeding peptic ulcer-a randomized trial[J].Endoscopy201547(8):680-687.
[26]
Cheng AWChiu PWChan PC,et al.Endoscopic hemostasis for bleeding gastric stromal tumors by application of hemoclip[J].J Laparoendosc Adv Surg Tech A200414(3):169-171.
[27]
安彦军,张佑蕊,乔钰.晚期消化道恶性肿瘤出血患者内镜下硬化剂及组织胶止血效果观察[J].肿瘤研究与临床202234(4):295-297.
[28]
Hussein MAlzoubaidi DO'Donnell M,et al.Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes[J].J Gastroenterol Hepatol2021, 36(11): 3027-3032.
[29]
Linghu E.A new stage of surgical treatment: super minimally invasive surgery[J].Chin Med J (Engl)2021135(1):1-3.
[30]
令狐恩强.手术发展史的新阶段-超级微创技术[J/CD].中华胃肠内镜电子杂志20163(3):97-98.
[31]
中华医学会消化内镜学分会. 消化内镜超级微创手术创面预处理与抗生素应用专家共识(2023年,北京)[J/CD].中华胃肠内镜电子杂志202310(2):83-96.
[32]
Han CLing XLiu J,et al.A new therapy for refractory gastric cancer bleeding:endoscopic ultrasound-guided lauromacrogol injection[J]. Endoscopy, 202254(4):E151-152.
[1] 邓华梅, 袁札根, 曾德荣, 潘珊珊, 张葆青, 欧爱华, 曹学伟. 全膝关节置换术中气压止血带应用效果与影响因素分析[J]. 中华关节外科杂志(电子版), 2023, 17(06): 788-794.
[2] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[3] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[4] 袁成雪, 张宗霞, 许婷, 斯郎拉姆. 三种内镜手术治疗结肠息肉的效果及安全性观察[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 78-81.
[5] 陈航, 闵翔. 日间甲状腺切除术后出血的12例临床分析及应对措施[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 600-602.
[6] 林文斌, 郑泽源, 郑文能, 郁毅刚. 外伤性脾破裂腹腔镜脾切除术患者中转开腹风险预测模型构建[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 619-623.
[7] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[8] 孙欣欣, 刘军, 陈超伍, 孙超. 超声内镜引导细针穿刺抽吸术在胰腺占位性病变中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 418-421.
[9] 秦维, 王丹, 孙玉, 霍玉玲, 祝素平, 郑艳丽, 薛瑞. 血清层粘连蛋白、Ⅳ型胶原蛋白对代偿期肝硬化食管胃静脉曲张出血的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 447-451.
[10] 高显奎, 赵太云, 陆兴俊, 张洪领, 房修罗, 闫碧春, 王胤, 王永翠, 刘苗苗, 冉若男. 内镜电凝止血与组织胶注射治疗上消化道溃疡伴出血的疗效观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 452-455.
[11] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[12] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[13] 邱春华, 张志宏. 1108例小肠疾病的临床诊断及检查策略分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 948-954.
[14] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
[15] 孟科, 李燕, 闫婧爽, 闫斌. 胶囊内镜胃通过时间的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 671-675.
阅读次数
全文


摘要